FindTrial
Sign In

Incidence and Clinical Characteristics of Herpes Zoster After Liver Transplantation

Incidence and Clinical Characteristics of Herpes Zoster After Liver Transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005599
Enrollment
450
Registered
2020-11-13
Start date
2020-03-28
Completion date
Unknown
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University Yangsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: adult (age =18 years) patients underwent liver transplantation

Exclusion criteria

Exclusion criteria: Patients with the following conditions were excluded: death within 4 weeks after Liver transplantation or insufficient or no follow-up data.

Design outcomes

Primary

MeasureTime frame
herpes zoster incidence—

Secondary

MeasureTime frame
age at liver transplantation;cause of liver transplantation;model for end-stage liver disease (MELD) score;postherpetic neuralgia incidence—

Countries

Korea, Republic of

Contacts

Public ContactEun-Ji Choi

Pusan National University Yangsan Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026